PD-L1 IHC Antibodies with Ultra Specificity & Sensitivity: Tested and Proven

This short video is an introduction on how OriGene has utilized its proprietary UltraMAB and TrueRAB technologies to develop a panel of anti-PD-L1 monoclonal antibodies with superior performance on IHC. For more information about OriGene products and services, please visit http://www.origene.com.